Is acetylcholine a signaling molecule for human colon cancer progression?

Scandinavian Journal of Gastroenterology

Volumn 46, Issue 4, 2011, Pages 446-455

  Novotny, Ann ^a   Ryberg, Kristin ^b   Heiman Ullmark, Jenny ^c   Nilsson, Linn ^d   Khorram Manesh, Amir ^a   Nordgren, Svante ^a   Delbro, Dick S ^a,b   Nylund, Gunnar ^e  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b KARLSTAD UNIVERSITY   (Sweden)

^c Section of Haematology   (Sweden)

^d CENTRAL HOSPITAL   (Sweden)

^e Section of Hematology   (Sweden)

Author keywords

Acetylcholine; choline acetyltransferase; colon cancer; nicotinic acetylcholine receptor; SLURP 1

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; BUNGAROTOXIN RECEPTOR; CHOLINE ACETYLTRANSFERASE; PLASMINOGEN ACTIVATOR INHIBITOR; SECRETED MAMMALIAN LY6 UROKINASE TYPE PLASMINOGEN ACTIVATOR RECEPTOR RELATED PROTEIN 1; TUMOR MARKER; UNCLASSIFIED DRUG;

ACETYLCHOLINE RELEASE; ADULT; AGED; ARTICLE; BIODEGRADATION; CANCER GROWTH; CANCER STAGING; CLINICAL ARTICLE; COLON; COLON BIOPSY; COLON CARCINOGENESIS; COLON MUCOSA; COLON RESECTION; CONTROLLED STUDY; FEMALE; HEMICOLECTOMY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PERIKARYON; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; SIGMOIDECTOMY; WESTERN BLOTTING;

ACETYLCHOLINE; ACETYLCHOLINESTERASE; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, LY; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CELL TRANSFORMATION, NEOPLASTIC; CHOLINE O-ACETYLTRANSFERASE; COLONIC NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RECEPTORS, NICOTINIC; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 79952600431     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2010.539252     Document Type: Article

References (30)

1. Washington MK. Colorectal carcinoma: selected issues in pathologic examination and staging and determination of prognostic factors. Arch Pathol Lab Med 2008;132: 1600-7.
2. Williams ST, Beart RW. Staging of colorectal cancer. Semin Surg Oncol 1992;8:89-93.
3. Li F-Y, Lai M-D. Colorectal cancer, one entity or three. J Zhejiang Univ Sci B 2009;10:219-29.
4. Bianco R, Melisi D, Ciardiello F, Tortora G. Key cancer cell signal transduction pathways as therapeutic targets. Eur J Cancer 2006;42:290-4.
5. Schuller HM. Is cancer triggered by altered signalling of nicotinic acetylcholine receptors? Nat Rev Cancer 2009;9: 195-205.
6. Horiuchi Y, Kimura R, Kato N, Fujii T, Seki M, Endo T, et al. Evolutional study on acetylcholine expression. Life Sci 2003;72:1745-56.
7. Westfall TC, Westfall DP. Neurotransmission: the autonomic and somatic motor nervous systems. In: Brunton LL, Lazo JS, Parker KL, editors. Goodman & Gilman's the pharmacological basis of therapeutics. 11th ed. New York: McGraw-Hill; 2005. pp 137-81.
8. Wessler I, Kirkpatrick CJ. Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans. Br J Pharmacol 2008;154:1558-71.
9. Cheng K, Samimi R, Xie G, Shant J, Drachenberg C, Wade M, et al. Acetylcholine release by human colon cancer cells mediates autocrine stimulation of cell proliferation. Am J Physiol Gastrointest Liver Physiol 2008;295: G591-7.
10. Frucht H, Gazdar AF, Park JA, Oie H, Jensen RT. Characterization of functional receptors for gastrointestinal hormones on human colon cancer cells. Cancer Res 1992;52: 1114-22.
11. Frucht H, Jensen RT, Dexter D, Yang WL, Xiao Y. Human colon cancer cell proliferation mediated by the M3 muscarinic cholinergic receptor. Clin Cancer Res 1999;5:2532-9.
12. Yang W-L, Frucht H. Cholinergic receptor up-regulates COX-2 expression and prostaglandin E2 production in colon cancer cells. Carcinogenesis 2000;21:1789-93.
13. Ukegawa JI, Takeuchi Y, Kusayanagi S, Mitamura K. Growth-promoting effect of muscarinic acetylcholine receptors in colon cancer cells. J Cancer Res Clin Oncol 2003;129: 272-8.
14. Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003;421:384-8.
15. de Jonge WJ, Ulloa L. The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation. Br J Pharmacol 2007;151:915-29.
16. Wong HP, Yu L, Lam EK, Tai EK, Wu WK, Cho CH. Nicotine promotes cell proliferation via alpha7-nicotinic acetylcholine receptor and catecholamine-synthesizing enzymesmediated pathway in human colon adenocarcinoma HT-29 cells. Toxicol Appl Pharmacol 2007;221:261-7.
17. Pettersson A, Nilsson L, Nylund G, Khorram-Manesh A, Nordgren S, Delbro DS. Is acetylcholine an autocrine/paracrine growth factor via the nicotinic alpha7-receptor subtype in the human colon cancer cell line HT-29? Eur J Pharmacol 2009;609:27-33.
18. Novotny A, Edsparr K, Nylund G, Khorram-Manesh A, Albertsson P, Nordgren S, Delbro DS. A pharmacological analysis of the cholinergic regulation of urokinase-type plasminogen activator secretion in the human colon cancer cell line, HT-29. Eur J Pharmacol 2009;646:22-30.
19. Grando SA. Basic and clinical aspects of non-neuronal acetylcholine: biological and clinical significance of noncanonical ligands of epithelial nicotinic acetylcholine receptors. J Pharm Sci 2008;106:174-9.
20. Pettersson A, Nordlander S, Nylund G, Khorram-Manesh A, Nordgren S, Delbro DS. Expression of the endogenous, nicotinic acetylcholine receptor ligand, SLURP-1, in human colon cancer. Auton Autocoid Pharmacol 2008;28:109-16.
21. Tsai H-L, Chu K-S, Huang Y-H, Su Y-C, Wu J-Y, Kuo CH, et al. Predictive factors of early relapse in UICC stage I-III colorectal cancer patients after curative resection. J Surg Oncol 2009;100:736-43.
22. Arias HR, Richards VE, Ng D, Ghafoori ME, Le V, Mousa SA. Role of non-neuronal nicotinic acetylcholine receptors in angiogenesis. Int J Biochem Cell Biol 2009; 41:1441-51.
23. Klapproth H, Reinheimer T, Metzen J, Münch M, Bittinger F, Kirkpatrick CJ, et al. Non-neuronal acetylcholine, a signalling molecule synthezied by surface cells of rat and man. Naunyn-Schmiedeberg's Arch Pharmacol 1997; 355:515-23.
24. Porter AJ, Wattchow DA, Brookes SJH, Schemann M, Costa M. Choline acetyltransferase immunoreactivity in the human small and large intestine. Gastroenterology 1996;111:401-8.
25. Jönsson M, Norrgård O, Forsgren S. Presence of marked nonneuronal cholinergic system in human colon: study of normal colon and colon in ulcerative colitis. Inflamm Bowel Dis 2007;13:1347-56.
26. Gill SK, Bhattacharya M, Ferguson SSG, Rylett RJ. Identification of a novel nuclear localization signal common to 69- and 82-kDa human choline acetyltransferase. J Biol Chem 2003;278:20217-24.
27. Massoulié J, Bon S, Perrier N, Falasca C. The C-terminal peptides of acetylcholinesterase: cellular trafficking, oligomerization and functional anchoring. Chem Biol Interact 2005;157-158:3-14.
28. Syed M, Fenoglio-Preiser C, Skau KA, Weber GF. Acetylcholinesterase supports anchorage independence in colon cancer. Clin Exp Metastasis 2008;25:787-98.
29. Montenegro MF, Ruiz-Espejo F, Campoy FJ, Muñoz- Delgado E, de la Cadena MP, Rodrígeuz-Berrocal FJ, Vidal CJ. Cholinesterases are down-expressed in human colorectal carcinoma. Cell Mol Life Sci 2006;63:2175-82.
30. Pettersson A, Nylund G, Khorram-Manesh A, Nordgren S, Delbro DS. Nicotine induced modulation of SLURP-1- expression in human colon cancer cells. Auton Neurosci 2009;148:97-100.